192 related articles for article (PubMed ID: 38835710)
1. Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review.
Melchor J; Prajapati S; Pichardo RO; Feldman SR
Skin Appendage Disord; 2024 Jun; 10(3):172-179. PubMed ID: 38835710
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
4. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
[TBL] [Abstract][Full Text] [Related]
5. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa.
González-López MA
Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
[TBL] [Abstract][Full Text] [Related]
7. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
[TBL] [Abstract][Full Text] [Related]
8. New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: infection, autoimmunity, or both?
Constantinou CA; Fragoulis GE; Nikiphorou E
Ther Adv Musculoskelet Dis; 2019; 11():1759720X19895488. PubMed ID: 31908656
[TBL] [Abstract][Full Text] [Related]
10. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.
Scuderi N; Monfrecola A; Dessy LA; Fabbrocini G; Megna M; Monfrecola G
Skin Appendage Disord; 2017 May; 3(2):95-110. PubMed ID: 28560220
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
Harvey LM; Fortson JK
Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa: Where We Are and Where We Are Going.
Scala E; Cacciapuoti S; Garzorz-Stark N; Megna M; Marasca C; Seiringer P; Volz T; Eyerich K; Fabbrocini G
Cells; 2021 Aug; 10(8):. PubMed ID: 34440863
[TBL] [Abstract][Full Text] [Related]
13. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.
Navrazhina K; Frew JW; Gilleaudeau P; Sullivan-Whalen M; Garcet S; Krueger JG
J Allergy Clin Immunol; 2021 Jun; 147(6):2213-2224. PubMed ID: 33548397
[TBL] [Abstract][Full Text] [Related]
14. TNF-α inhibitors in the treatment of hidradenitis suppurativa.
Savage KT; Flood KS; Porter ML; Kimball AB
Ther Adv Chronic Dis; 2019; 10():2040622319851640. PubMed ID: 31191873
[TBL] [Abstract][Full Text] [Related]
15. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
[TBL] [Abstract][Full Text] [Related]
16. Brodalumab for severe hidradenitis suppurativa: a case of clinico-radiologic improvement and literature review.
Vagnozzi E; Bruni M; Esposito M; Fargnoli MC
J Dermatolog Treat; 2023 Dec; 34(1):2270091. PubMed ID: 37842732
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa.
Sabat R; Jemec GBE; Matusiak Ł; Kimball AB; Prens E; Wolk K
Nat Rev Dis Primers; 2020 Mar; 6(1):18. PubMed ID: 32165620
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance Imaging of Hidradenitis Suppurativa: A Focus on the Anoperineal Location.
Srisajjakul S; Prapaisilp P; Bangchokdee S
Korean J Radiol; 2022 Aug; 23(8):785-793. PubMed ID: 35914743
[TBL] [Abstract][Full Text] [Related]
19. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa: Molecular Etiology, Pathophysiology, and Management-A Systematic Review.
Diaz MJ; Aflatooni S; Abdi P; Li R; Anthony MR; Neelam S; Farkouh C; Tran JT; Svoboda S; Forouzandeh M; Valdes Rodriguez RH
Curr Issues Mol Biol; 2023 May; 45(5):4400-4415. PubMed ID: 37232749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
